Acquisition Opportunity WCG Clinical acquired Statistics Collaborative in January 2020, indicating potential cross-sell opportunities for WCG Clinical’s broader trial solutions and ongoing biostatistical support needs across drug, biologic, and device programs.

Mid-market Focus Company size of 11-50 employees positions it as a mid-market client with sizable annual revenue, suggesting a need for scalable, cost-effective biostatistical services and flexible engagement models.

Therapeutic Emphasis Specialization in cardiovascular, infectious diseases, orphan diseases, and vaccines presents opportunities to cross-sell statistical design, DSMC data analysis, and regulatory consultation to similar therapeutic programs.

Regulatory Readiness Experience supporting FDA presentations and data monitoring committees indicates readiness for compliant analytics, reporting, and regulatory interactions, enabling targeted offerings around submission-ready analyses and audit trails.

Tech & Content Tech stack and web presence (Snowplow, WordPress, SEO tools) show potential for analytics-driven marketing automation, client portal integrations, and streamlined data visualization services to enhance engagement and reporting.